Showing 101-110 of 1560 results for "".
Assessing Advancements in Treatment Options for Small Cell Lung Cancer
https://reachmd.com/programs/spotlight-lung-cancer/assessing-advacements-in-treatment-options-for-small-cell-lung-cancer/12113/How has the small cell lung cancer treatment landscape changed, and how will this impact the field of oncology?Balancing Benefits and Risks in Emerging Sickle Cell Therapies
https://reachmd.com/programs/project-oncology/balancing-benefits-and-risks-in-emerging-sickle-cell-therapies/36236/For decades, hydroxyurea has been the cornerstone therapy for sickle cell disease, but new disease-modifying therapies, curative strategies, and gene therapies are expanding options for patients. While these advancing approaches come with some risks, they can help offer symptom relief, reduce compliDifferentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
https://reachmd.com/programs/project-oncology/differentiating-large-cell-neuroendocrine-carcinoma-from-other-lung-cancers/36459/Properly differentiating between small cell lung cancer, large cell neuroendocrine carcinoma, and other lung cancer subtypes is important in choosing the right treatment for patients. Hear Dr. Balazs Halmos discuss key differences in the diagnostic and therapeutic processes of these cancers and howAlcohol Use Among Sickle Cell Patients
https://reachmd.com/programs/clinicians-roundtable/alcohol-use-among-sickle-cell-patients/3013/Alcohol abuse is a common concern for many patients afflicted with chronic pain conditions. What are we learning about alcohol use specific to patients with sickle cell anemia? Is alcohol perhaps more help than hindrance? Dr. James Levenson, professor of psychiatry, medicine and surgery at the VirgiCurrent Updates on Squamous Cell Cancer of the Head and Neck (SCCHN)
https://reachmd.com/programs/global-oncology-academy/current-updates-on-squamous-cell-cancer-of-the-head-and-neck-scchn/8582/Join Jan B. Vermorken, MD, PhD as he shares some of the exciting updates on Squamous Cell Cancer of the Head & Neck (SCCHN).T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
https://reachmd.com/programs/project-oncology/t-cell-characteristics-key-players-in-bispecific-antibody-treatment-success/26580/T-cell bispecific antibodies (BsAbs) have emerged as a promising immunotherapy approach in cancer treatment.The Immunomodulating Role of B Cells in IgA Nephropathy: Focus On APRIL
https://reachmd.com/programs/medical-industry-feature/the-immunomodulating-role-of-b-cells-in-iga-nephropathy-focus-on-april/29534/IgA Nephropathy Is a Progressive, Autoimmune, Chronic Kidney Disease and the Most Common Primary Glomerulonephritis Worldwide. B-cells and cytokines, such as A Proliferating Ligand (APRIL), play a key role in the pathogenesis of this disease. Hear expert insights about the roles B cells and APRIL plToxic Short RNAs May Cause Neuronal Cell Death in Alzheimer’s Disease
https://reachmd.com/programs/neurofrontiers/toxic-short-rnas-may-cause-neuronal-cell-death-in-alzheimers-disease/17829/Dive into a study that investigated how toxic short RNAs may lead to neuronal cell death in Alzheimer's disease.Evidence Builds for Cell-Based Influenza Vaccines
https://reachmd.com/programs/medical-industry-feature/evidence-cell-based-influenza-vaccines/36269/Randomized controlled trials have shown data supporting the safety and efficacy of cell-based influenza vaccines in adults and children.1-4 However, effectiveness studies have historically relied on outcomes based on clinical diagnosis of influenza-like illness rather than test-confirmed influenza.5First Cell-Based Gene Therapy for RDEB
https://practicaldermatology.com/series/dermwire-tv/first-cell-based-gene-therapy-for-rdeb/35742/In this week's DermwireTV, the FDA approves the first cell-based gene therapy for recessive dystophic epidermolysis bullosa (RDEB); a new acne scar treatment using focal point technology is cleared in the US; and in our “Updates on Skin Cancer” feature, we hear about the advantages of 40-GEP testing